The largest database of trusted experimental protocols

3 protocols using macsquant analyser 10 flow cytometer

1

PSCA-Targeted Polyplex Delivery and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Binding of biotinylated scFv(AM1)-P-BAP to PSCA-positive target cells and isogenic parental cells was analyzed by flow cytometry. 2 × 105 cells were stained with 5 μg scFv-P-BAP for 1 h at 4 °C, followed by secondary anti-biotin-VioBlue antibody (Miltenyi Biotec, Cologne, Germany). Cells stained with the secondary antibody alone served as the control. To evaluate the targeted delivery of DNA, 2 × 105 293TPSCA cells were incubated with scFv-P-BAP hybrid polyplexes loaded with Cy3-labelled plasmid DNA (Mirus Bio, Madison, WI, USA, plasmid # MIRUMIR7904, 2.7 kb) for 4 h at 37 °C. Cy3-plasmid-loaded hybrid polyplexes conjugated with control scFv(MR1.1)-P-BAP were included as a negative control. Subsequently, the cells were washed with 0.1% Heparin/PBS (Sigma-Aldrich). To evaluate the transfection efficiency, 1 × 105 293TPSCA were incubated with PPI:MC-GFP dendriplexes containing 1 µg MC-DNA and PPI at different mass ratios for 48 h. At least 2 × 104 cells were measured by MACSQuant Analyser 10 flow cytometer (Miltenyi Biotec) and analyzed by FlowJo software version 10.1 (TreeStar, Ashland, OR, USA).
+ Open protocol
+ Expand
2

Isolation of Human Peripheral Blood Mononuclear Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cells were isolated from buffy coats using density gradient. For this, 25 ml of blood from healthy donors (German Red Cross, Frankfurt, Germany) were mixed with the same amount of Hank’s balanced salt solution (Thermo Fisher Scientific, Oberhausen, Germany) and were layered over 15 ml of Biocoll (Merck, Darmstadt, Germany) in Sep-Mate™-50 tubes (Stemcell Technologies, Cologne, Germany). Tubes were centrifuged (1200 g, 10 min, RT), and human peripheral blood mononuclear cells were isolated from the interphase, washed with 2 mM EDTA/PBS four times and counted using a MACSQuant® Analyser 10 flow cytometer (Miltenyi Biotec, Bergisch Gladbach, Germany). Defined amounts of cells were dissolved in 0.5% bovine serum albumin/2 mM EDTA/PBS and incubated with 25% (v/v) human CD14 MicroBeads for 15 min at 4 °C. Afterwards magnetically labelled cells were separated via magnetic cell separation with LS columns (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s protocol. Cell count was determined with flow cytometry.
+ Open protocol
+ Expand
3

Comprehensive Immune Profiling of CAR T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAR T cells (2×105 cells per test) were labeled with antibodies at 4°C for 15 min. Flow cytometry was performed using a MACSQuant Analyser 10 Flow Cytometer (Miltenyi Biotec, Bergisch Gladbach, Germany), and data were analyzed by FlowJo V.10.7.1 software (FlowJo). Cells were subjected to SSc-FSc and gated as the CD3+ T-cell population. For transfection efficiency: CD19 CAR detection reagent, anti-biotin PE, and CD3-APC (Miltenyi Biotec, Bergisch Gladbach, Germany); T-cell phenotype: CD3-PerCP (UCHT1), CD8-PE (SK1), (BD Bioscience, New Jersey, USA), CD4-APC (BioLegend, San Diego, California, USA); memory phenotype: CD3-PerCP (UCHT1), CD45RO-VioGreen (UCHL1), and CD62L-VioBlue (DREG-56) (BD Bioscience, New Jersey, USA); exhaustion: CD3-PerCP, PD1(CD279)-APC, TIM-3-PE, LAG3-PE, and TIGIT-APC (BioLegend, San Diego, California, USA); activation: CD3-PerCP, CD25-PE, and CD69-APC (BioLegend, San Diego, California, USA); and for cytolytic activity: CD3-PE (OKT3), CD19-APC (HIB19) (BioLegend, San Diego, California, USA), and 7AAD-PerCP (BD Bioscience, New Jersey, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!